Sakar Healthcare Limited (NSE:SAKAR)
India flag India · Delayed Price · Currency is INR
460.80
+14.05 (3.14%)
Feb 16, 2026, 3:29 PM IST

Sakar Healthcare Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
2,3091,7761,5341,3341,282947.39
Other Revenue
5.225.228.168.338.915.72
2,3141,7811,5421,3421,291953.12
Revenue Growth (YoY)
35.15%15.53%14.89%3.93%35.47%13.58%
Cost of Revenue
1,097824.14842.09737.45748.77514.6
Gross Profit
1,217956.93699.59604.47542.41438.52
Selling, General & Admin
417.51317.32198.62169.35153.55132.82
Other Operating Expenses
206.45133.66106.7394.185.8173.86
Operating Expenses
855.01659.8485.85413.3336.04287.26
Operating Income
361.84297.13213.73191.17206.38151.26
Interest Expense
-90-78.97-67.45-54.88-25.88-23.34
Interest & Investment Income
0.180.181.253.930.560.16
Currency Exchange Gain (Loss)
7.47.417.2334.4911.625.85
Other Non Operating Income (Expenses)
3.29-6.57-8.71-4.75-3.22-1.61
EBT Excluding Unusual Items
282.71219.18156.06169.96189.46132.33
Gain (Loss) on Sale of Investments
--2.94-0.62-
Gain (Loss) on Sale of Assets
-3.39-3.39----
Other Unusual Items
--0.51--0.05--
Pretax Income
279.32215.27159169.91190.08132.33
Income Tax Expense
27.140.2542.2942.3337.6525.5
Net Income
252.21175.02116.71127.59152.43106.83
Net Income to Common
252.21175.02116.71127.59152.43106.83
Net Income Growth
69.71%49.96%-8.53%-16.30%42.69%11.01%
Shares Outstanding (Basic)
222221191515
Shares Outstanding (Diluted)
222221191515
Shares Change (YoY)
2.26%6.20%11.49%23.33%-0.77%
EPS (Basic)
11.387.975.646.8610.117.09
EPS (Diluted)
11.377.955.636.8610.117.09
EPS Growth
65.96%41.21%-17.95%-32.13%42.69%10.17%
Free Cash Flow
-17.5-350.93-488.51-109.08-209.69
Free Cash Flow Per Share
-0.80-16.93-26.27-7.24-13.91
Gross Margin
52.59%53.73%45.38%45.05%42.01%46.01%
Operating Margin
15.64%16.68%13.86%14.25%15.98%15.87%
Profit Margin
10.90%9.83%7.57%9.51%11.80%11.21%
Free Cash Flow Margin
-0.98%-22.76%-36.40%-8.45%-22.00%
EBITDA
576.69496.85393.27341.03279.66206.34
EBITDA Margin
24.92%27.90%25.51%25.41%21.66%21.65%
D&A For EBITDA
214.86199.72179.54149.8673.2855.08
EBIT
361.84297.13213.73191.17206.38151.26
EBIT Margin
15.64%16.68%13.86%14.25%15.98%15.87%
Effective Tax Rate
9.70%18.70%26.60%24.91%19.81%19.27%
Revenue as Reported
2,3321,7891,5651,3801,304959.15
Advertising Expenses
-0.070.070.280.220.06
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.